Crinetics Pharma’s hormonal disorder drug meets main goal in late-stage study

(Reuters) – Crinetics Pharmaceuticals said on Tuesday its experimental drug to treat a hormonal disorder met the main goal in a late-stage study.

(Reporting by Sneha S K; Editing by Shilpi Majumdar)